SpiroChem | News | SpiroChem | Tailor-Made Molecules

SpiroChem: the key partner of successful Biotechs.

Testimonials

September 4, 2018

SpiroChem: the key partner of successful Biotechs.

Drug Discovery Services at SpiroChem SpiroChem: the key partner of successful Biotechs. Using a wealth of scientific and technical expertise, we tackle problems and develop exclusive, timely and cost-effective solutions. SpiroChem has played an instrumental part in Cellestia’s drug discovery and development program, proving to be a reliable partner in delivering quality results in a timely manner. Within the framework of this collaboration, the team has spared no effort in meticulously executing the plan and actively participating in project meetings to contribute to...

SpiroChem Fragment Library: Your key to successful drug discovery

New Products & Concept

August 31, 2018

SpiroChem Fragment Library: Your key to successful drug discovery

Your key to successful drug discovery SpiroChem Fragment Library Our designed libraries, with more complex fragments (typically 3D small molecules) provide excellent entry into drug discovery programs. Our rationale is that scaffolds with a three-dimensional character may have better affinity and stronger binding to biological targets. This comes from the simple observation that all natural products, i.e. biologically relevant proteins and their ligands, are chiral and three-dimensional. Explore new chemical space with our premium sp3-enriched fragment libraries. While it may reduce the number of...

SpiroChem @ EFMC-ISMC 2018 - XXV EFMC International Symposium on Medicinal Chemistry

Conferences

August 29, 2018

SpiroChem @ EFMC-ISMC 2018 - XXV EFMC International Symposium on Medicinal Chemistry

SpiroChem @ EFMC-ISMC 2018 - XXV EFMC International Symposium on Medicinal Chemistry Ljubljana, Slovenia from 2-6 September, 2018 SpiroChem will be participating at the XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018), held in Ljubljana, Slovenia from 2-6 September, 2018. Our team will be there to discuss SpiroChem’s innovative approach in the design and synthesis of novel building blocks. This has paved the way for modern drug discovery programs and will continue to foster innovations in the field of medicinal chemistry. Visit us...

A word from Dr. Thomas Fessard, CEO @ SpiroChem

Press Release

August 21, 2018

A word from Dr. Thomas Fessard, CEO @ SpiroChem

A word from Dr. Thomas Fessard, CEO @ SpiroChem When it comes to innovation, not even Basel’s soaring temperatures can stop us. It has been a hot summer so far and we have hot news coming! We aspire to continuously expand our offer. That is why we constantly reshape and revisit our product lines and services in order to help you accelerate your drug discovery programs. Our elite team of chemists are wired to tackle challenges, pushing the frontiers of chemistry to...

SpiroChem @ 54th International Conference on Medicinal Chemistry (RICT 2018)

Conferences

June 26, 2018

SpiroChem @ 54th International Conference on Medicinal Chemistry (RICT 2018)

SpiroChem @ 54th International Conference on Medicinal Chemistry Strasbourg, France July 4-6, 2018 SpiroChem is taking part in the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018), organized by the French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) from July 4-6, 2018 in Strasbourg, France. The conference is devoted to “Interfacing Chemical Biology and Drug Discovery" while SpiroChem poster presentations will describe our results on new chemical spaces, namely: - the synthesis of new strained building blocks via...